Guan, Jun, Qin Yang, Chao Chen, Gang Wang, and Haihong Zhu. “Prognostic Value of Low Skeletal Muscle Mass in Hepatocellular Carcinoma Patients Treated With Sorafenib or Lenvatinib: A Meta-Analysis”. EXCLI Journal 20 (January 4, 2021): 1–16. Accessed May 2, 2024. https://www.excli.de/index.php/excli/article/view/3111.